(1)
Efficacy of Nivolumab in Comparison to Chemotherapy and Gefitinib for Advanced NSCLC. J. Bangladesh Coll. Phys. 2024, 42 (2), 176-188. https://doi.org/10.3329/jbcps.v42i2.72362.